Trade Secrets and Confidential Know-how

Trade secrets and other confidential know-how are the lifeblood of your business. They can secure innovation and help you to maintain a strong market position. In some situations, confidentiality might be preferable to patent protection. However, developing strategies to prevent misuse and theft is essential to preserving...

Representative experience

Conducting a six-month study published by the European Commission on trade secrets law: completing a comparative law assessment of protection against infringement in Member States.

Acting for a global chemical company in a dispute in the UK and U.S. relating to industrial secrets of a world leading antibiotic formula.

Successfully defending respondent uPI Semiconductor Corporation in an ITC enforcement proceeding alleging violation of a Consent Order by trade secret misappropriation and patent infringement.

Acting for a global life sciences business in UK litigation relating to alleged trade secrets infringement in the formulation of pesticides.

Advising a petroleum company on the protection of confidential know-how licensed to it and possible actions relating to a plant in danger of being seized.

Successfully defended a large communications company against damages claims alleging that our client misappropriated trade secrets in connection with the development of air-to-ground telephone technology.

Successfully represented a biotech company relating to alleged trade secrets theft by a venture capital firm seeking to invest in our client and a competitor. 

Advising a major software company in a case involving allegations of trade secrets theft relating to operating system software for our client's largest computer systems.

Acting for a trading firm to recover business critical confidential source code from a former employee and their new employer, involving simultaneous 24 hour search orders.

Representing uPI Semiconductor in a defense of Richtek Technology’s complaint for trade secret misappropriation in California state court.

Advising an international medical device company on suspected infringement of its trade secrets by one of its key ex-employees.

Advising Solvay Co. Ltd. in their defense of a trade secret misappropriation action brought in connection with the manufacturing process of the synthetic chemical vanillin.

Hogan Lovells Publications

A guide to NYDFS Cybersecurity Regulation's March 1 implementation deadline Privacy and Cybersecurity Alert

It’s been almost a year since the New York State Department of Financial Services (NYDFS) Cybersecurity Regulation (23 NYCRR Part 500) came into effect (see our discussion here)....

Quick view Full view

Hogan Lovells Publications

Global IP outlook 2018

2017 was a year of widespread political, technological, and legal changes; leading to lack of certainty and creating both challenges and opportunities for businesses in 2018 and beyond.

Quick view Full view

Hogan Lovells Publications

Patents or Trade Secrets? Yes, Please.

Most energy companies implement Intellectual Property (“IP”) strategies to protect and exploit company IP (offense) and navigate third-party rights...

Quick view Full view

Press Releases

Hogan Lovells Partners Named as 2017 BTI Client Service All-Stars

WASHINGTON, 7 February 2017 – Hogan Lovells is pleased to announce that partners Steven Barley, John Booher, Zenas Choi, Robert Hawk, Mitch Lazris, Michael Silver, and Cullen Taylor...

Quick view Full view

Hogan Lovells Publications

Rolling back the clock – What the new administration and Congress can do to halt or delay the Obama administration's midnight regulations Health Alert

In the waning months of the Obama Presidency, the exiting administration could finalize new regulations. These so-called “midnight regulations” could affect major sectors of the ...

Quick view Full view

Hogan Lovells Publications

French Legal and Regulatory Newsletter French Legal and Regulatory Newsletter

The Paris office of Hogan Lovells is pleased to provide an overview of the main French and EU regulatory developments from the past months.

Quick view Full view
Loading data